Abstract
To the Editor: In the ALPINE trial involving patients with relapsed or refractory chronic lymphocytic leukemia (CLL), Brown and colleagues (Jan. 26 is......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
